European Journal of Inorganic Chemistry p. 3728 - 3735 (2007)
Update date:2022-08-04
Topics:
Budzisz, Elzbieta
Malecka, Magdalena
Keppler, Bernhard K.
Arion, Vladimir B.
Andrijewski, Grzegorz
Krajewska, Urszula
Rozalski, Marek
Novel platinum(II) and palladium(II) complexes [PtCl2(HL 1)] (3a), [NH2CH3)2][PtCl 2(L1)] (3b), [PdCl2(HL1)] (4a), [NH2(CH3)2][PdCl2(L1)] (4b) and [PdCl(CH3CN)(L1)] (4c), where HL1 = 4-(2-hydroxybenzoyl)-2-(pyridin-2-yl)-1H-pyrazol-3-ol, have been synthesised as potential anticancer compounds. Protonation constants of the ligand were determined by pH-metric titration (log K1 = 7.74 ± 0.03; log K2 = 2.85 ± 0.05). The solid-state structures of complexes 3b and 4c have been determined by X-ray diffraction, showing sguare-planar coordination geometry of PtII and PdII ions. In addition, the compounds have been characterised by IR, 1H NMR and FAB mass spectrometry. The results of preliminary studies on the cytotoxic activity in vitro against HL-60 and NALM-6 leukaemia cell lines are also reported and the IC50 values compared with those of the metal-free ligand and cisplatin. Cytotoxic evaluation revealed that PtII and Pd II complexes were active in the micromolar concentration range. Wiley-VCH Verlag GmbH & Co. KGaA, 2007.
View MoreShijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Zibo Xiaoguang Chemical Material Co., Ltd
Contact:15954099116
Address:Boshan Development Zone
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
Hangzhou Zyter Biological & Chemical Technology Co., Ltd.
website:http://www.zyterpharm.com
Contact:+86-18858184290
Address:West Wenyi Road, Cangqian, Yuhang
Wuhan Chemwish Technology Co., Ltd
website:http://www.chemwish.com/
Contact:+86-27-67849912
Address:Room 1311, Unit 2, Block1, Innovation Road East Lake High-tech Development Zone Wuhan, Hubei,P.R. China
Doi:10.1021/jo00111a036
(1995)Doi:10.1021/om8005454
(2008)Doi:10.1021/jo01105a032
(1958)Doi:10.1021/jm00391a012
(1987)Doi:10.1007/BF00945511
()Doi:10.1002/hlca.200890159
(2008)